Lombard Odier Asset Management Switzerland SA Acquires New Stake in Cigna Group $CI

Lombard Odier Asset Management Switzerland SA acquired a new stake in Cigna Group (NYSE:CI) during the 1st quarter, Holdings Channel reports. The institutional investor acquired 2,950 shares of the health services provider’s stock, valued at approximately $787,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of CI. Brighton Jones LLC increased its position in shares of Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares during the period. Sivia Capital Partners LLC grew its stake in Cigna Group by 10.4% in the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after purchasing an additional 109 shares in the last quarter. NewEdge Advisors LLC grew its stake in Cigna Group by 4.5% in the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock worth $7,347,000 after purchasing an additional 958 shares in the last quarter. Treasurer of the State of North Carolina increased its holdings in Cigna Group by 16.6% during the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock worth $49,204,000 after purchasing an additional 21,173 shares during the period. Finally, Osterweis Capital Management Inc. bought a new stake in Cigna Group during the 2nd quarter valued at $163,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CI. Cantor Fitzgerald raised their price target on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Piper Sandler cut their target price on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 3rd. Raymond James Financial set a $340.00 price target on shares of Cigna Group in a report on Friday, May 1st. Wells Fargo & Company upped their price target on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research report on Friday, May 1st. Finally, Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, June 20th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and an average target price of $338.80.

Insider Buying and Selling at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This represents a 85.46% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is owned by insiders.

Cigna Group Stock Performance

CI stock opened at $291.35 on Tuesday. Cigna Group has a one year low of $239.51 and a one year high of $315.47. The firm has a market cap of $77.07 billion, a price-to-earnings ratio of 12.35, a PEG ratio of 1.12 and a beta of 0.29. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a 50-day simple moving average of $286.15 and a two-hundred day simple moving average of $280.80.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. During the same quarter in the previous year, the business posted $6.74 EPS. Cigna Group’s revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities analysts forecast that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio is currently 26.45%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.